CD4 and neoplasm: The binding of BCRs and tumor antigens not only increases the secretion of cytokines that induce the activation of CD4+ T cells, CD8+ T cells, and NK cells, but also directly kills tumor cells through the secretion of cytolytic molecules, such as GZMB and TRAIL [49].